| Literature DB >> 24348647 |
Abbas Alipour1, Abbas Rezaianzadeh2, Jafar Hasanzadeh2, Abdorreza Rajaeefard2, Mohammad Ali Davarpanah3.
Abstract
BACKGROUND: Overall, 60-70% of the hepatitis c virus (HCV) transmission routes is parenteral, and in 30-40% of the cases is unknown (e.g. sexual route). Knowing these routes in HIV infected dyads is very important due to clinical and methodological reasons.Entities:
Keywords: HIV; Hepatitis C Virus; Transmission
Year: 2013 PMID: 24348647 PMCID: PMC3859182 DOI: 10.5812/hepatmon.13593
Source DB: PubMed Journal: Hepat Mon ISSN: 1735-143X Impact factor: 0.660
Characteristics of HIV Infected Persons and their Main Heterosexual Partners, Shiraz (Southern of Iran), 2011
| Characteristics | HIV infected persons (Actors) | Partners | Dyads | P value [ |
|---|---|---|---|---|
|
| 38.71 ± 7 | 33.2 ± 6.28 | < 0.0001 | |
|
| 2/166 | 166/2 | < 0.0001 | |
|
| 17.8 ± 4.54 | 23.82 ± 6.69 | < 0.0001 | |
|
| 25.02 ± 6.25 | 35.5 ± 9.18 | < 0.0001 | |
|
| 161 (95.8) | 10 (6) | < 0.0001 | |
|
| 128 (76.2) | 6 (3.6) | < 0.0001 | |
|
| 108 (64.3) | 3 (1.8) | < 0.0001 | |
|
| 109 (64.9) | 24 (14.3) | < 0.0001 | |
|
| 126 (75) | 18 (10.7) | < 0.0001 | |
|
| 16 (9.52) | 0 (0) | < 0.0001 | |
| 3.7 ±3 | ||||
| 11.91 ± 8.02 | ||||
| 6.35 ± 5.06 | ||||
|
| 150 (98.2) | |||
|
| 24 (14.3) | 50 (29.8) | < 0.0001 | |
|
| 118 (70.2) | 19 (11.3) | < 0.0001 | |
|
| ||||
| Concordant negative | 21 (12.5) | |||
| Concordant positive | 16 (9.52) | |||
| Actor positive/partner negative | 131 (77.98) | |||
| Actor negative/female positive | 0 (0) | |||
|
| ||||
| Concordant negative | 0 (0) | |||
| Concordant positive | 77 (46.95) | |||
| Actor positive/ partner negative | 91 (53.05) | |||
| Actor negative/ partner positive | 0 (0) |
aHolm-Sidak adjusted P value
Multilevel Logistic Regression Estimates of Risk Factors/Cofactorsand Theory -Derived Interaction Effects on Actor Anti-HCV Positivity [a ], Shiraz (southern of Iran), 2011
| HCV State | OR (95% CI) | ||
|---|---|---|---|
| Negative | Positive | ||
|
| |||
|
| |||
| No | 160 (62) | 98 (38) | 3.5 (2.01- 6.1) |
| yes | 13 (16.7) | 65 (83.3) | |
|
| |||
| No | 164 (81.2) | 38 (18.8) | 60.3 (27.4- 126.5) |
| yes | 9 (6.7) | 125 (93.3) | |
|
| |||
| No | 168 (74.7) | 57 (25.3) | 47.5 (19.9- 113.3) |
| yes | 5 (4.5) | 106 (95.5) | |
|
| |||
| No | 149 (73.4) | 54 (26.6) | 7.3 (4.4- 12.1) |
| yes | 24 (18) | 109 (82) | |
|
| |||
| No | 146 (76) | 46 (24) | 9.8 (5.5- 16.3) |
| yes | 27 (18.8) | 117 (81.2) | |
| Number of tattooing points | 0.37 (0) | 2.1 (1) | 1.9 (2.3- 1.5) |
|
| |||
| No | 153 (66.5) | 77 (33.5) | 4.9 (2.9- 8.3) |
| yes | 18 (17.3) | 86 (82.7) | |
|
| 0 (0) | 0.35 (0) | 23.4 (23.01- 23.7) |
|
| |||
|
| 33.4 ± 6.75 | 38.66 ± 7.08 | 1.7 (1.1- 2.4) |
|
| |||
| Female | 152 (90.5) | 16 (9.5) | 66.5 (33.31- 132.8) |
| male | 21 (12.5) | 147 (87.5) | |
|
| 298 ± 187.6 | 585 ± 279.8 | 0.996 (0.995- 0.997) |
|
| |||
| Negative | 84 (96.6) | 3 (3.4) | 20.1 (8.8- 48.4) |
| Positive | 86 (35.1) | 159 (64.9) | |
|
| |||
| No | 33 (24.1) | 104 (75.9) | 3.9 (2.4- 6.2) |
| yes | 140 (70.4) | 59 (29.6) | |
|
| |||
| No | 163 (86.2) | 26 (13.8) | 198.3 (21.1- 1863.1) |
| yes | 10 (6.8) | 137 (93.2) | |
|
| |||
|
| |||
| No | 143 (69.4) | 63 (30.6) | 4.4 (2.7- 7.2) |
| yes | 33 (27.7) | 86 (72.3) | |
|
| |||
| Negative | 165 (68.5) | 7 (31.5) | 5.56 (3.3- 10) |
| Positive | 11 (12.6) | 76 (87.4) | |
|
| |||
| No | 61 (31) | 136 (69) | 0.17 (0.11- 0.28) |
| yes | 118 (87.4) | 17 (12.6) | |
|
| |||
| No | 136 (93.2) | 10 (6.8) | 46.7 (23.5- 93.1) |
| yes | 43 (23.1) | 143 (76.9) | |
|
| |||
|
| 42 (25) | 1.46 (1.458- 1.462) | |
|
| |||
|
| 0.019 (0.002- 0.18) | ||
|
| 23.42 (23.11- 23.73) | ||
aOther independent variables which had not significant association (P > 0.2) with actor HCV status (were not show in this table) are as follows: Actor level: Condom use in sexual activity with non-main heterosexual partner, Current condom use with casual partner, drug use at sexual activity with non-main heterosexual partner time, history of blood transfusion, history of blood transfusion before 1992, number of blood transfusion, age of the first sexual activity, age of the first sexual activity with main heterosexual partner, age of the first drug use, age of the first IDU, total leukocyte count, sexual transmitted disease, education level, homosexual activity Partner level: age, age of the first sexual activity, age of the first drug use, age of the first IDU, CD4 level, total leukocyte count, education level Couple level: razor sharing, drug use at sexual activity with main heterosexual partner time, number of sexual activities with main partner in previous month, Duration of sexual relationship, age difference between them Theory-derived interaction effects: Actor IDU, moderated by Actor HIV positive, sex; Actor tattooing moderated by sex, Actor lifetime incarceration; Sexual activity with non main heterosexual partner moderated by Actor HIV positive, sex; Actor no. of sexual acts with main partner in previous month moderated by Actor HIV positive, Partner HCV positive, Partner HIV positive.
Multilevel Logistic Regression Estimation of Individual and Couple Level Risk Factors for Actor Anti-HCV Positivity, Final Model, Shiraz (southern of Iran), 2011
| Effects [ | β | SE | Adjusted Odds Ratio (95% CI) |
|---|---|---|---|
|
| 2.57 | 0.62 | 13.03 (3.9-43.82) |
|
| 1.57 | 0.49 | 4.81 (1.84-12.55) |
|
| 1.96 | 0.84 | 7.1 (1.37-36.97) |
|
| 2.18 | 0.52 | 8.83 (3.16-24.78) |
|
| 1.89 | 0.92 | 6.6 (1.1-39.6) |
aRandom effect (level 2 variance component)